MedTrace Logo

Shared Decision Making on Radiation Dose for Lung Malignancies

NCT04940936 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-11

No results posted yet for this study

Summary

A Patient Decision Aid (PtDA) is developed during a workshop in close collaboration with selected patients. The PtDA is subsequently used in the consultation between patient and physician to facilitate their shared decision on the dose of stereotactic body radiation therapy (SBRT) for lung tumors located less than 1 cm from the thoracic wall.

Hypothesis: The use of a PtDA will increase the extent of Shared Decision Making (SDM) during the consultation and result in patients being more directly involved in the planning of their treatment.

Conditions

  • Decision Making, Shared
  • Stereotactic Body Radiation Therapy
  • Lung Cancer, Non-small Cell
  • Radiation Toxicity
  • Lung Metastases

Interventions

BEHAVIORAL

A Patient Decision Aid

The Patient Decision Aid informs about the pros and cons of each option

Sponsors & Collaborators

  • Vejle Hospital

    lead OTHER

Principal Investigators

  • Thomas L Fink, MD · Department of Oncology, Vejle Hospital

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-12
Primary Completion
2026-01-30
Completion
2031-03-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04940936 on ClinicalTrials.gov